Fecal Microbiota Transplantation in aGvHD After ASCT | MicrobiomeTrials← Back to trialsNCT03819803
Fecal Microbiota Transplantation in aGvHD After ASCT
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2017-03-01Est. Completion: 2027-03-01
Enrollment target: 15 participants Locations- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Styria, Austria
Other microbiome trials you might be interested in
Steroid Refractory Graft Versus Host Disease
The purpose of this study is to determine the efficacy and safety of CK0802 Tregs for treatment of refractory GVHD (graf…
Multiple LocationsEst. completion Jun 30, 2028
Gingivitis; ChronicGingivitis and Periodontal DiseasesDental Plaque
Dental plaque is a major etiological factor in the development of gingivitis. Mechanical plaque control through toothbru…
Etāwah, IndiaCompleted Dec 31, 2022
Phase 2
Recruiting
Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
This randomized placebo-controlled double-blind phase II trial tests whether fecal microorganism (microbiota) transplant…
Seattle, United StatesEst. completion Aug 12, 2026